Study suggests Pfizer COVID-19 vaccine may only partially protect against Omicron : vimarsana.com

The Omicron variant of the coronavirus can partially evade the protection from two doses of Pfizer Inc and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday.

Related Keywords

South Africa , Japan , United States , Bengaluru , Karnataka , India , New Jersey , Lisa Shumaker , Manas Mishra , Shounak Dasgupta , Alex Sigal , Anthony Fauci , Thomson Reuters Trust Principles , World Health Organization On Nov , Twitter , Reuters , Pfizer , Pfizer Inc , Africa Health Research Institute , World Health Organization , Michael Erman , Thomson Reuters Trust , M 28q , Biodrg , Blr , Cmpny , Gen , Hea , Heca , Medst , Mrch , News1 , Phag08 , Phar , Phar08 , Phar1 , Phmr , Ceeu , Weu , Amers , Afr , Us , Europ , Ezc , Namer , De , Mtpix , Covid , Genhlt , Humdis , Infdis , Intag , Oms , Pubhea , Pxp , Un1 , Vaccin , Topnws , Immogy , Sci , Topcmb , Ef Business Future Of Health , Chld , Mrch1 , Publ , Soci ,